Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Common financial budgeting issues can disrupt your financial goals. Learn to identify and address these challenges for better budgeting.
19,311 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Bitcoin closed June at a two-year low as ETF outflows accelerated and institutional interest remained restrained. The...
Toyota announces a $3.6 billion investment to relocate Tacoma pickup production from Mexico to its San Antonio plant,...
If SpaceX ever issued bonds, investors might treat them like junk debt due to high leverage and concentrated revenue....
Berkshire Hathaway’s cash pile nears the $400 billion mark, renewing scrutiny on what the conglomerate will do with v...
Walmart's price cuts bring relief to shoppers, but a broad cost-of-living squeeze pushes retirees to rethink Social S...
A quiet dividend king in the utility space could be the sleeper winner you’ve been waiting for. This article explains...
AI-driven investment has become a major growth engine for the U.S. economy, but a slowdown could ripple across jobs, ...
A surge in triple-leveraged ETFs has driven notional exposure to about $500 billion, intensifying daily volatility an...
New fiscal data show that the cost of servicing the national debt is on track to exceed Medicare spending this year, ...
A recent enforcement operation in Maine ended with a fatal shooting after a vehicle attempted to flee. The incident r...
As of July 16, 2026, Brent crude sits around $84.64 per barrel, easing slightly after yesterday’s pullback. The curre...